Tesla
Dividend Schedule
Stock Rankings
ETF Rankings
Crypto Rankings
See Graham's ranking
4.0
Kenvue Inc. is a global consumer health company focused on personal care, hygiene, and over-the-counter health products. The company was created through the separation of Johnson & Johnson’s consumer health division, forming an independent entity dedicated to consumer brands.
• Owns widely recognized brands such as Neutrogena, Listerine, Tylenol, Band-Aid, Johnson’s Baby, and Aveeno.
• Operates across multiple consumer health categories, including skin care, oral care, pain relief, and infant care.
• Distributes products through retail stores, pharmacies, and e-commerce channels worldwide.
• Maintains a global presence with operations and distribution networks across more than 100 countries.
• Competes with major consumer goods companies in the global personal health and hygiene market.
Kenvue’s portfolio consists of established consumer brands with long market histories in areas such as skin care, oral hygiene, baby care, and over-the-counter medications. The company focuses on brand management, product innovation, and global distribution to maintain its position in the consumer health market.
Its products are sold through a combination of retail partnerships, pharmacies, supermarkets, and digital platforms. The company operates across North America, Europe, Asia, and other international markets.
Kenvue Inc. is listed on the Nasdaq under the ticker KVUE.
History and Development
Kenvue was created following the separation of Johnson & Johnson’s consumer health division, allowing the new company to focus exclusively on personal care and over-the-counter health products.
The spin-off enabled the business to operate independently with its own management structure, financial strategy, and brand portfolio while maintaining the legacy of several well-known consumer brands.
The company completed its initial public offering in 2023, marking its debut as an independent public company in the consumer health sector.
Today, Kenvue operates globally with a strategy centered on brand expansion, product innovation, and strengthening its presence in the personal health and hygiene market.
Additional Information
Kenvue Inc. (United States) is listed on the Nasdaq and has a market capitalization of $36.47 billion, with shareholders equity totaling $10.61 billion.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Kenvue Inc. reported $15.29 billion in revenue, generating net income of $1.62 billion.
Key financial metrics include a P/E ratio of 22.49, a price-to-book (P/B) ratio of 3.44, and a trailing twelve-month dividend yield of 4.38%.
The company trades under the ticker KVUE.
